Law360, New York (July 18, 2012, 7:19 PM ET) -- An Oklahoma federal judge ruled Wednesday that Novartis Pharmaceutical Corp. cannot be held liable for the jaw deterioration of an Aredia and Zometa user because there is no indication different advice from his physician would have prevented his condition.
U.S. District Judge Tim Leonard granted summary judgment to the drugmaker, in a suit that was part of the multidistrict litigation in Tennessee over injuries allegedly caused by the bone drugs before it was remanded to Oklahoma for trial.